Chapter Member Anniversaries: January 2022

Posted by ISPE Boston
On January 4, 2022

Please congratulate the following members celebrating milestone anniversaries in January 2022. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Michael Anderson, FST Technical Services LLC Mara Bartos, Sanofi Genzyme Daniel Baxter, Vertex Pharmaceuticals Incorporated Anthony Bevilacqua, Mettler-Toledo Thornton Inc William Bohnaker, Abzena Erik Caldwell, Northeast Water Svcs, […]

Welcome New Members December 2021!

Posted by ISPE Boston
On January 4, 2022

We would like to introduce the Members who joined ISPE in December 2021, welcome them to the Chapter and encourage them (and all our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And the […]

Seasons Greetings from ISPE Boston!

Posted by ISPE Boston
On December 22, 2021

There is no more fitting time to say Thank You and to wish our volunteers, board of directors, committee members, and members a Happy Holiday Season and a New Year filled with health, happiness and good fortune. We sincerely appreciate everything you all do to support ISPE and wouldn’t be where we are today without […]

Lilly and Foghorn Announce Strategic Collaboration

Posted by ISPE Boston
On December 16, 2021

Foghorn Therapeutics and Loxo Oncology at Lilly, a research and development group of Eli Lilly, have entered into a strategic collaboration to create novel oncology medicines by applying Foghorn’s proprietary Gene Traffic Control platform, a tool for understanding and modulating the chromatin regulatory system which regulates gene expression by directing the movement of molecules that […]

Setting Career Intentions for 2022

Posted by Jayne Mattson
On December 16, 2021

What better time of the year to start thinking about your career intentions for 2022! Many career professionals spent the majority of 2021 adjusting to their companies’ work environments, changing responsibilities and challenges. Employees returned to full time in the office, a hybrid model or continued to work virtually and will continue into 2022. What […]

FREE Job Posting Service Available!

Posted by ISPE Boston
On December 13, 2021

Are you a recent grad or a seasoned career professional seeking new job opportunities in the Boston area? Or maybe you’re a recruiter or hiring manager tasked with finding the best and brightest candidates to fill your job openings? Look no further – the ISPE Boston Area Chapter website has you covered! We are currently […]

Blueprint Medicines to Acquire Lengo Therapeutics

Posted by ISPE Boston
On December 9, 2021

Blueprint Medicines will acquire San Diego-based Lengo Therapeutics, a privately held precision oncology company, for $250 million in cash plus up to $215 million in additional potential payments based on the achievement of certain regulatory approval and sales-based milestones. Lengo Therapeutics is developing novel, small molecule precision therapeutics that target driver mutations in oncology. The company’s initial focus is […]

Vertex Demonstrates Proof of Concept for Genetically-Targeted Drug For Kidney Disease

Posted by ISPE Boston
On December 8, 2021

Vertex Pharmaceuticals has announced positive results from a small, Phase 2 proof-of-concept (POC) study of investigational drug VX-147 in patients with APOL1-mediated kidney disease. Based on these data, Vertex plans to advance VX-147 into pivotal development in Q1 2022 as a potential first-in-class therapy for the more than 100,000 patients with kidney disease mediated by […]

Drug Giant Novo Nordisk to Acquire Dicerna for $3.3 Billion

Posted by ISPE Boston
On December 8, 2021

Dicerna Pharmaceuticals, a biopharmaceutical company focused on the development of investigational ribonucleic acid interference (RNAi) therapeutics, is being acquired by Danish drug giant Novo Nordisk for $38.25 per share in cash, which represents a total equity value of $3.3 billion and a premium of 80% to Dicerna’s closing price on November 17, 2021. Dicerna’s RNAi technology platform enables access to […]

Now Showing: Fast Track Delivery Webinar

Posted by ISPE Boston
On December 7, 2021

On November 18th, the Boston Area Chapter presented “Fast track Delivery: Balancing Capital Projects and Operations” via Zoom Webinar. This panel discussion covered project management techniques where activities are performed in parallel, instead of being carried out sequentially. Speakers included Dennis Lucey, Managing Director at PMA Consultants; Eric Karch, Senior Director of Global Reagent Manufacturing, […]

Page 39 of 117«‹37 383940 41 ›»